We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FDA drug approvals were down 16 percent in 2019 compared with 2018, a reduction that predates the COVID-19 outbreak, according to data and analytics firm GlobalData. Read More
Moderna previously received fast-track designations for three of its messenger RNA vaccine programs, including its investigational Zika vaccine. Read More
The FDA has granted Moderna’s COVID-19 vaccine candidate a fast-track designation, making it the first potential vaccine to receive the agency’s expedited review status. Read More